Alexion Pharmaceuticals, Inc.
Compositions comprising an anti-C5 antibody
Last updated:
Abstract:
The present application relates to methods and compositions employing an antibody that inhibits activation of the complement system and can be used to prevent or treat a pulmonary disease or condition.
Status:
Grant
Type:
Utility
Filling date:
4 Oct 2018
Issue date:
19 Nov 2019